Results 231 to 240 of about 85,963 (263)

Case Report: The JAK-Inhibitor Ruxolitinib Use in Aicardi-Goutieres Syndrome Due to ADAR1 Mutation

Frontiers in Pediatrics, 2021
Raffaele Badolato, Silvia Clara Giliani, Simona Orcesi   +2 more
exaly  

JAK Inhibitors

2021
openaire   +1 more source

Effect of the JAK/STAT Inhibitor Tofacitinib on Macrophage Cholesterol Metabolism

International Journal of Molecular Sciences, 2023
Nicoletta Ronda, Maria Orietta Borghi, Franco Bernini   +2 more
exaly  

The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells

International Journal of Molecular Sciences, 2020
Kwan Ho Jeong, Hoon Kang, Donggeon Lee
exaly  

JAK INHIBITOR

2022
TAKEIRI MASATOSHI, MORIYA AYUKA, ARAI KEIKO, KIMURA YOSHIHIDE   +3 more
openaire   +1 more source

INHIBITORS OF JAK

2010
BAUER SHAWN M, ROSE JACK W, SONG YONGHONG, XU QING, MEHROTRA MUKUND, HUANG WOLIN, PANDEY ANJALI   +6 more
openaire   +4 more sources

CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms

Cancer Cell, 2015
Sara Christina Meyer, Raajit Rampal, Dmitry Pankov   +2 more
exaly  

JAK inhibitor

2017
WU HAO, MAO WEIWEI, FAN LILI, DING CHARLES Z, CHEN SHUHUI, WANG FEI, HU GUOPING, LI JIAN   +7 more
openaire   +4 more sources

Jak inhibitor ; possibility and mechanism as a new disease modifying anti-rheumatic drug

Japanese Journal of Clinical Immunology, 2009
Kunihiro Yamaoka, Yoshiya Tanaka
exaly  

PAN-JAK Inhibitors/Non-selective JAK Inhibitors

Salih Levent Çınar, Fatih Can Aba
openaire   +1 more source